Predict your next investment

HEALTHCARE | Medical Facilities & Services / Medical Laboratories & Research
chinesepeptide.com

See what CB Insights has to offer

Stage

Acquired | Acquired

Valuation

$0000 

About Chinese Peptide

Chinese Peptide is committed to R&D and manufacturing of peptide in drugs and research reagent field. As a globally-leading peptide player, the company has the capacity to produce kilo-scale cGMP peptide, providing one-stop solution satisfying the needs from research to commercialization.

Chinese Peptide Headquarter Location

Hangzhou Economic and Technological Development Zone No.69, 12 Street

Hangzhou, Zhejiang , 310 018,

China

86-0571-86737118

Latest Chinese Peptide News

Week in Review Xinbang Pharma Acquires Chinese Peptide Co. for $323 Million

May 10, 2015

Verify here. The information provided by BioPortfolio.com is not a substitute forprofessional medical advice, diagnosis or treatment. The BioPortfoliosite is sponsored BioPortfolio Limited with offices at Stafford House,10 Prince of Wales Road, Dorchester, DT1 1PW, England. If youare a legal copyright holder or a designated agent for such and you believe apost on this website falls outside the boundaries of “Fair Use” andlegitimately infringes on your or your client's copyright we may be contactedconcerning copyright matters at: priority@bioportfolio.com. All rights reserved. All other trademarks recognized. Copyright© 1997-2015 BioPortfolio Limited. Site developed by Alacrify Ltd .

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.